Methotrexate Increases Response to Pegloticase in Patients With Uncontrolled Gout
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Arthritis Research & Therapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
Arthritis Res. Ther. 2022 Aug 25;24(1)208, JK Botson, JRP Tesser, R Bennett, HM Kenney, PM Peloso, K Obermeyer, Y Song, B LaMoreaux, L Zhao, Y Xin, J Chamberlain, S Ramanathan, ME Weinblatt, J PetersonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.